Health Canada
- Status: approved
🇨🇦 Triptorelin acetate （3.75mg） in Canada
Triptorelin acetate （3.75mg） (Triptorelin acetate （3.75mg）) regulatory status in Canada.
Marketing authorisation
Triptorelin acetate （3.75mg） in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Triptorelin acetate （3.75mg） approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Triptorelin acetate （3.75mg） in Canada?
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.